Citadel Advisors’s Adial Pharmaceuticals ADIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-54,508
| Closed | -$55.1K | – | 5877 |
|
|
2024
Q4 | $55.1K | Buy |
54,508
+21,238
| +64% | +$21.5K | ﹤0.01% | 5433 |
|
|
2024
Q3 | $33.2K | Buy |
33,270
+8,524
| +34% | +$8.52K | ﹤0.01% | 5220 |
|
|
2024
Q2 | $28.5K | Buy |
+24,746
| New | +$28.5K | ﹤0.01% | 5331 |
|
|
2022
Q4 | – | Sell |
-10,602
| Closed | -$93K | – | 6020 |
|
|
2022
Q3 | $93K | Buy |
+10,602
| New | +$93K | ﹤0.01% | 5142 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5945 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6268 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6382 |
|
|
2021
Q3 | – | Sell |
-808
| Closed | -$52K | – | 6327 |
|
|
2021
Q2 | $52K | Sell |
808
-2,164
| -73% | -$139K | ﹤0.01% | 6191 |
|
|
2021
Q1 | $180K | Sell |
2,972
-107
| -3% | -$6.48K | ﹤0.01% | 5487 |
|
|
2020
Q4 | $131K | Buy |
+3,079
| New | +$131K | ﹤0.01% | 4618 |
|
|
2019
Q2 | – | Sell |
-1,060
| Closed | -$91K | – | 4599 |
|
|
2019
Q1 | $91K | Buy |
+1,060
| New | +$91K | ﹤0.01% | 4112 |
|